It is reported that the total investment of the production line is about 60 million yuan, and it is equipped with four fully automatic precision fermentation production lines. These production lines are all equipped with advanced automated separation and purification systems, which can monitor various key parameters in the production process in real time, ensuring comprehensive, efficient, and precise control of product quality. The successful delivery of this project not only demonstrates Sanxi Group's profound technical accumulation in the field of synthetic biological equipment manufacturing, but also demonstrates its efficient project management and delivery capabilities.

In recent years, with the continuous development of technologies such as gene editing and artificial intelligence, synthetic biology has sparked a new wave of research. Scientists have high hopes for this cutting-edge science, hoping to use this technology to improve human health, address food crises, alleviate global warming and other common problems faced by humanity.
Driven by both policy support and technological progress, the synthetic biology market has ushered in unprecedented development opportunities. Its application fields are extensive, covering multiple key areas such as medicine, agriculture, energy, and environmental governance. By 2024, the global synthetic biology market size will reach 20.8 billion US dollars, and by 2030, the global synthetic biology market size will grow to 77.5 billion US dollars. This scale of growth not only reflects the enormous market potential of synthetic biotechnology, but also reflects the strong global demand for synthetic biology products.

For enterprises, the introduction of synthetic biotechnology aims to reduce dependence on natural resources, increase product added value, and enhance the stability and resilience of the supply chain. Especially in the field of plant extraction, the application of synthetic biotechnology will effectively alleviate the risks caused by fluctuations in raw material supply, providing a solid guarantee for the production of high-purity and low-cost rare ingredients.

We firmly believe that with the continuous iteration of technology and the continuous expansion of application scenarios, food and beverage and agriculture will become the two core areas for the future development of synthetic biology technology, "said Jiang Dawei, Chairman of Sanxi Group, in an interview with the media." These two areas not only have huge market demand, but are also closely related to people's lives, and are the key to achieving a win-win situation for social value and economic benefits of synthetic biology technology

As a pioneer in the field of synthetic biological equipment manufacturing, Sanxi Group deeply understands that the success of every project is a recognition of innovation and trust in cooperation. Therefore, the group will continue to deepen communication and cooperation with the industry, provide more scientific and intelligent manufacturing solutions for synthetic biology production line equipment to global customers, and contribute its own strength to promoting the transformation and implementation of achievements in the field of synthetic biology and industrial upgrading.

Source: https://pharm.jgvogel.cn/c1450570.shtml